SCHEMBL10921245

SCHEMBL10921245

Cc1cncc2c([N+](=O)[O-])c(Cl)ccc12

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.40
▸ TDP1 Q9NUW8 2/20 0.39
▸ TSHR P16473 4/20 0.36
▸ LMNA P02545 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ MEN1 O00255 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ MAPT P10636 2/20 0.33
▸ CRHBP P24387 1/20 0.33
▸ CRHR2 Q13324 1/20 0.33
▸ ALPL P05186 1/20 0.33
▸ ALPI P09923 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ TNF P01375 1/20 0.33
▸ MCL1 Q07820 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ VCAM1 P19320 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9422167 0.76 ALDH1A1 (0.50) ALDH1A1TDP1TSHRMAPK1MAPT
SCHEMBL19765250 0.75 ALDH1A1 (0.42) ALDH1A1TDP1TSHRLMNAMAPK1
SCHEMBL11741012 0.73 CYP2A6 (0.34) MAPT
SCHEMBL4633923 0.72 ALDH1A1 (0.56) ALDH1A1TDP1TSHRMEN1KMT2A
SCHEMBL10923361 0.72 HASPIN (0.47) ALDH1A1TSHRHTTMEN1KMT2A
SCHEMBL7784706 0.71 ALDH1A1 (0.56) ALDH1A1TDP1TSHRHSD17B10TNF
SCHEMBL11160686 0.71 ALDH1A1 (0.71) ALDH1A1LMNAHTTMEN1KMT2A
SCHEMBL29735720 0.70 ALDH1A1 (0.54) ALDH1A1TDP1TSHRMEN1KMT2A
SCHEMBL18434559 0.70 CCR1 (0.52) ALDH1A1TDP1TSHRLMNAHTT
SCHEMBL7514813 0.70 ALDH1A1 (0.56) ALDH1A1TDP1TSHRMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0074741-B1 METHOD OF PRODUCING ALPHA2 ANTAGONISM SMITHKLINE BECKMAN CORPORATION (US) 1986-11-12 — — EP disclosed
EP-0023761-B1 TETRAHYDROISOQUINOLINE DERIVATIVES, PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM SMITHKLINE BECKMAN CORPORATION (US) 1984-03-07 — — EP disclosed
EP-0074741-A1 Method of producing alpha2 antagonism SMITHKLINE BECKMAN CORPORATION (US) 1983-03-23 — — EP disclosed
US-4352809-A THIADIAZOLO- AND OXADIAZOLOTETRAHYDROISOQUINOLINES, ANTIDEPRESSANTS SMITHKLINE CORPORATION (US) 1982-10-05 — — US disclosed
US-4258049-A Inhibiting phenylethanolamine N-methyltransferase with thiadiazolo and oxadiazolotetrahydroisoquinolines SMITHKLINE CORPORATION (US) 1981-03-24 — — US disclosed
EP-0023761-A1 Tetrahydroisoquinoline derivatives, process for preparing them and compositions containing them SMITHKLINE BECKMAN CORPORATION (US) 1981-02-11 — — EP disclosed
Send feedback